1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Common neurotransmitter systems studied in PET imaging and radioligands used for each component or pathway involved
Neurotransmitter System Component/Pathway Involved Radioligands Used Serotonin Synthesis α-[11C]MTrp Transport [11C]McNeil 5652 [11C]DASB Type 1A receptor [11C]WAY-100635 [18F]FCWAY [18F]MPPF Type 1B receptor [11C]P943 Type 2 receptor [18F]setoperone [18F]altanserin [11C]MDL 100907 [18F]FESP Dopamine Synthesis [18F]fluoro-L-DOPA D1 receptor [11C]SCH 23,390 [11C]NNC 112 D2/3 receptor [11C]raclopride [11C]FLB 457 Transporter [11C]RTI-32 [11C]CFT Monoamine oxidase Monoamine oxidase type A [11C]harmine Non-monoaminergic mechanisms Muscarinic type 2 receptor [18F]FP-TZTP Nicotinic receptor [18F]FA-85380 GABA type A receptor [11C]flumazenil Phosphodiesterase type 4 [11C]-(R)-rolipram Amyloid and τ proteins [18F]DDNP p-glycoprotein [11C]verapamil Histamine H1 receptor [11C]doxepin